New heart sensor aims to keep patients out of hospital
NCT ID NCT07442903
Summary
This study is testing a small, implanted sensor that continuously monitors pressure in the lung artery to help manage heart failure. It will be used in 30 patients with severe tricuspid valve leakage who are scheduled for a minimally invasive valve repair procedure. The goal is to see if this remote monitoring can help doctors adjust medications early and reduce the need for hospital stays after the procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH SEVERE TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
LMU Klinikum
NOT_YET_RECRUITINGMunich, Germany
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LMU Munich
RECRUITINGMünchen, Germany
Conditions
Explore the condition pages connected to this study.